SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ProStrakan Group's ABSTRAL(R) (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.